Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 10, 2009, Pages 1714-1726

  Beaumont, Marine ^a,b   Lemasson, Benjamin ^a,b,c   Farion, Régine ^a,b   Segebarth, Christoph ^a,b   Rémy, Chantal ^a,b   Barbier, Emmanuel L ^a,b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Oncodesign   (France)

Author keywords

Blood volume; Brain tumors; Dynamic contrast enhanced MRI; Ultrasmall superparamagnetic iron oxide particles; Vessel size index

Indexed keywords

GADOTERATE MEGLUMINE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLIOMA; HISTOPATHOLOGY; MALE; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TUMOR LOCALIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL MEMBRANE PERMEABILITY; CONTRAST MEDIA; DEXTRANS; FERROSOFERRIC OXIDE; GADOLINIUM; GLIOMA; HETEROCYCLIC COMPOUNDS; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR;

EID: 70349656652     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2009.86     Document Type: Article

References (38)

1. Barbier EL, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13:496-520
2. Batchelor TT, Sorensen AG, di TE, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83-95
3. Beaumont M, Lamalle L, Segebarth C, Barbier EL (2007) Improved k-space trajectory measurement with signal shifting. Magn Reson Med 58:200-205
4. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, Jain RK (2001) In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7:864-868
5. Buckley DL (2002) Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 47:601-606
6. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111
7. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
8. Cheng HL (2008) Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 28:736-743
9. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, Baleriaux D, Gaillard S, Dousset V (2004) Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 39:619-625
10. Daldrup HE, Link TM, Blasius S, Strozyk A, Könemann S, Jü rgens H, Rummeny EJ (1999) Monitoring radiationinduced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI. J Magn Reson Imaging 9:643-652
11. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997) Oligodendrogliomas. Part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34:37-59
12. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40:793-799
13. Everett NB, Simmons B, Lasher EP (1956) Distribution of blood (Fe 59) and plasma (I 131) volumes of rats determined by liquid nitrogen freezing. Circ Res 4:419-424
14. Ferretti S, Allegrini PR, O'Reilly T, Schnell C, Stumm M, Wartmann M, Wood J, McSheehy PM (2005) Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Clin Cancer Res 11:7773-7784
15. Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, Gupta SN, Choyke PL, Oldfield EH, Thomasson D, Butman JA (2007) Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia 9:546-555
16. Fonchy E, Lahrech H, Francois-Joubert A, Dupeyre R, Benderbous S, Corot C, Farion R, Rubin C, Decorps M, Remy C (2001) A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model. J Magn Reson Imaging 14:97-105
17. Gagner JP, Law M, Fischer I, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: imaging and experimental therapeutics. Brain Pathol 15:342-363
18. Gossmann A, Helbich TH, Kuriyama N, Ostrowitzki S, Roberts TPL, Shames DM, van Bruggen N, Wendland MF, Brasch RC (2002) Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 15:233-240
19. Hou LC, Veeravagu A, Hsu AR, Tse VC (2006) Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 20:E5 Kershaw LE, Buckley DL (2006) Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 56:986-992
20. Kim DH, Adalsteinsson E, Spielman DM (2003) Simple analytic variable density spiral design. Magn Reson Med 50:214-219
21. Kiselev VG, Strecker R, Ziyeh S, Speck O, Hennig J (2005) Vessel size imaging in humans. Magn Reson Med 53:553-563
22. Li X, Huang W, Yankeelov TE, Tudorica A, Rooney WD, Springer CS, Jr (2005) Shutter-speed analysis of contrast reagent bolus-tracking data: preliminary observations in benign and malignant breast disease. Magn Reson Med 53:724-729
23. Nag S, Robertson DM, Dinsdale HB (1981) Cerebrovascular permeability in mechanically induced hypertension. Can J Neurol Sci 8:215-220
24. Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, Greene AS (2001) MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med 46:735-747
25. Pathak AP, Ward BD, Schmainda KM (2008) A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method. Neuroimage 40:1130-1143
26. Petito CK (1979) Early and late mechanisms of increased vascular permeability following experimental cerebral infarction. J Neuropathol Exp Neurol 38:222-234
27. Pitman EJG (1937) Significance tests which may be applied to samples from any populations. Suppl J R Statist Soc 4:119-130
28. Port RE, Knopp MV, Brix G (2001) Dynamic contrastenhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn Reson Med 45:1030-1038
29. Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M (2004) Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed 17:163-169
30. Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Krouwer HG (2004) Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 25:1524-1532
31. Schwarzbauer C, Syha J, Haase A (1993) Quantification of regional blood volumes by rapid T1 mapping. Magn Reson Med 29:709-712
32. Shivers RR, Edmonds CL, Del Maestro RF (1984) Microvascular permeability in induced astrocytomas and peritumor neuropil of rat brain. A high-voltage electron microscope-protein tracer study. Acta Neuropathol 64:192-202
33. Takano S, Yoshii Y, Nose T (1991) [Ultrastructure of glioma vessel-morphometric study for vascular permeability]. No To Shinkei 43:49-56
34. Takei H, Bhattacharjee MB, Rivera A, Dancer Y, Powell SZ (2007) New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med 131:234-241
35. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)- weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223-232
36. Troprès I, Lamalle L, Péoc'h M, Farion R, Usson Y, Décorps M, Rémy C (2004) In vivo assessment of tumoral angiogenesis. Magn Reson Med 51:533-541
37. Uehara H, Miyagawa T, Tjuvajev J, Joshi R, Beattie B, Oku T, Finn R, Blasberg R (1997) Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions. J Cereb Blood Flow Metab 17:1239-1253
38. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C, Barbier EL (2008) Assessment of blood volume, vessel size and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 10:1043-1056